Evotec SE
A drug discovery and development partner for pharma, biotech, and academia.
EVT | F
Overview
Corporate Details
- ISIN(s):
- DE0005664809 (+1 more)
- LEI:
- 529900F9KI6OYITO9B12
- Country:
- Germany
- Address:
- Essener Bogen 7, 22419 Hamburg
- Website:
- https://www.evotec.com/en
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Evotec SE is a life science company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies, as well as academic institutions. The company offers a fully integrated research and development value chain, leveraging proprietary technology platforms and deep disease understanding to accelerate the creation of new medicines. Its expertise spans multiple therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics subsidiary, the company also provides advanced solutions for the design, development, and manufacturing of biologics. Evotec operates through flexible partnership models, aiming to enhance the speed, efficiency, and quality of bringing novel treatments to patients.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Evotec SE and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-16 12:07 |
Director's Dealing
Evotec SE: Paul Hitchin, buy
|
English | 5.9 KB | |
| 2025-09-15 11:56 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 62.2 KB | |
| 2025-09-11 16:40 |
Declaration of Voting Results & Voting Rights Announcements
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
|
English | 4.5 KB | |
| 2025-08-27 15:04 |
Director's Dealing
Evotec SE: Dr. Christian Wojczewski, buy
|
English | 5.9 KB | |
| 2025-08-20 11:29 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 54.3 KB | |
| 2025-08-13 07:00 |
Earnings Release
Evotec SE reports H1 2025 results: Strong progress on strategy execution
|
English | 18.4 KB | |
| 2025-08-13 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 613.3 KB | |
| 2025-08-11 16:40 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 59.5 KB | |
| 2025-08-06 09:52 |
Report Publication Announcement
Evotec SE to announce first half-year results 2025 on 13 August 2025
|
English | 11.3 KB | |
| 2025-07-30 07:16 |
M&A Activity
Evotec and Sandoz evolve their strategic partnership and agree on potential sal…
|
English | 14.5 KB | |
| 2025-07-23 15:34 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 56.9 KB | |
| 2025-07-21 11:40 |
Earnings Release
Evotec adjusts revenue guidance and confirms profit guidance anticipating a mor…
|
English | 13.3 KB | |
| 2025-07-15 11:35 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 56.9 KB | |
| 2025-06-30 11:00 |
Declaration of Voting Results & Voting Rights Announcements
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
|
English | 4.4 KB | |
| 2025-06-25 07:30 |
Regulatory News Service
Evotec joins NURTuRE-AKI consortium to gain multi-omics-based molecular underst…
|
English | 16.4 KB |
Automate Your Workflow. Get a real-time feed of all Evotec SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Evotec SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-06 | Dohrmann, Dr. Cord | Board | Other | None | 91,363.32 EUR |
| 2024-10-01 | Rouxel, Laetitia | Board | Other | None | 58,396.84 EUR |
| 2024-09-13 | Wojczewski, Dr. Christian | Board | Buy | None | 61,087.50 EUR |
| 2024-09-05 | Dalbiez, Aurélie | Board | Buy | None | 21,202.55 EUR |
| 2024-09-02 | Wojczewski, Dr. Christian | Board | Buy | None | 64,466.00 EUR |
| 2024-08-29 | Löw-Friedrich, Prof. Dr. Iris | Supervisory board | Buy | None | 100,050.00 EUR |
| 2024-08-23 | Wojczewski, Dr. Christian | Board | Buy | None | 113,291.94 EUR |
| 2024-08-22 | Johnstone, Dr. Craig | Board | Buy | None | 16,553.03 EUR |
| 2024-08-19 | Wojczewski, Dr. Christian | Board | Buy | None | 59,766.00 EUR |
| 2024-05-03 | Dohrmann, Dr. Cord | Board | Other | None | 76,220.10 EUR |
